The studies of Walker L. E. et al. [34] and Kamaşak et al. [35] demonstrated that patients with refractory epilepsy with structural changes had a higher total level of HMGB1 than the control group and the group with treatable epilepsy. The gene discussed is HMGB1; the disease is epilepsy.